Comparison of Acute Ischemic Stroke Care and Outcomes Between Comprehensive Stroke Centers and Primary Stroke Centers in the United States

Background: To improve stroke care, the Brain Attack Coalition recommended establishing primary stroke center (PSC) and comprehensive stroke center (CSC) certification. This study aimed to compare ischemic stroke care and in-hospital outcomes between CSCs and PSCs. Methods and Results: We analyzed patients with acute ischemic stroke who were hospitalized at stroke centers participating in Get With The Guidelines-Stroke from 2013 to 2015. Multivariable logistic regression models were generated to examine the association between stroke center certification (CSC versus PSC) and performances and outcomes. This study included 722 941 patients who were admitted to 134 CSCs and 1047 PSCs. Both CSCs and PSCs had good conformity to 7 performance measures and the summary defect-free care measure. Among emergency department admissions, CSCs had higher intravenous tPA (tissue-type plasminogen activator) and endovascular thrombectomy rates than PSCs (14.3% versus 10.3%, 4.1% versus 1.0%, respectively). Door to intravenous tPA time was shorter at CSCs (median, 52 versus 61 minutes; adjusted risk ratio, 0.92; 95% confidence interval, 0.89–0.95). More patients at CSCs had door to intravenous tPA time ⩽60 minutes (79.7% versus 65.1%; adjusted odds ratio, 1.48; 95% confidence interval, 1.25–1.75). For transferred patients, CSCs and PSCs had comparable overall performance in defect-free care, except higher endovascular thrombectomy therapy rates. The overall in-hospital mortality was higher at CSCs in both emergency department admissions (4.6% versus 3.8%; adjusted odds ratio, 1.14; 95% confidence interval, 1.01–1.29) and transferred patients (7.7% versus 6.8%; adjusted odds ratio, 1.17; 95% confidence interval, 1.05–1.32). In-hospital outcomes were comparable between CSCs and PSCs in patients who received intravenous tPA or endovascular thrombectomy. Conclusions: CSCs and PSCs achieved similar overall care quality for patients with acute ischemic stroke. CSCs exceeded PSCs in timely acute reperfusion therapy for emergency department admissions, whereas PSCs had lower risk-adjusted in-hospital mortality. This information may be important for acute stroke triage and targeted quality improvement.

[1]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.

[2]  Hester F. Lingsma,et al.  A randomized trial of intraarterial treatment for acute ischemic stroke. , 2015, The New England journal of medicine.

[3]  Eric E. Smith,et al.  Differences in Acute Ischemic Stroke Quality of Care and Outcomes by Primary Stroke Center Certification Organization , 2017, Stroke.

[4]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[5]  Peter Langhorne,et al.  European Stroke Organisation recommendations to establish a stroke unit and stroke center. , 2013, Stroke.

[6]  R E Latchaw,et al.  Recommendations for the establishment of primary stroke centers , 2000 .

[7]  Eric E. Smith,et al.  Representativeness of the Get With The Guidelines–Stroke Registry: Comparison of Patient and Hospital Characteristics Among Medicare Beneficiaries Hospitalized With Ischemic Stroke , 2012, Stroke.

[8]  Eric E. Smith,et al.  Increase in Endovascular Therapy in Get With The Guidelines-Stroke After the Publication of Pivotal Trials , 2017, Circulation.

[9]  M. Reeves,et al.  Quantifying Selection Bias in National Institute of Health Stroke Scale Data Documented in an Acute Stroke Registry , 2016, Circulation. Cardiovascular quality and outcomes.

[10]  Eric E. Smith,et al.  Data quality in the American Heart Association Get With The Guidelines-Stroke (GWTG-Stroke): results from a national data validation audit. , 2012, American heart journal.

[11]  Eric E. Smith,et al.  Development of Stroke Performance Measures: Definitions, Methods, and Current Measures , 2010, Stroke.

[12]  Adrian F Hernandez,et al.  Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. , 2013, JAMA.

[13]  E. Cumbler.  In-Hospital Ischemic Stroke , 2015, The Neurohospitalist.

[14]  M. Reeves,et al.  Characteristics and Outcomes of Stroke Patients Transferred to Hospitals Participating in the Michigan Coverdell Acute Stroke Registry , 2016, Circulation. Cardiovascular quality and outcomes.

[15]  Adnan H Siddiqui,et al.  Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. , 2016, JAMA.

[16]  Eric E. Smith,et al.  Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke , 2010, Circulation. Cardiovascular quality and outcomes.

[17]  Eric E. Smith,et al.  Variation and Trends in the Documentation of National Institutes of Health Stroke Scale in GWTG-Stroke Hospitals , 2015, Circulation. Cardiovascular quality and outcomes.

[18]  Andrew A. White,et al.  Interhospital transfer patients discharged by academic hospitalists and general internists: Characteristics and outcomes. , 2016, Journal of hospital medicine.

[19]  A. Rabinstein.  Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke , 2010 .

[20]  W. Burgin,et al.  ASPECTS decay during inter-facility transfer in patients with large vessel occlusion strokes , 2016, Journal of NeuroInterventional Surgery.

[21]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.